Fig. 3
From: KEAP1 mutations as key crucial prognostic biomarkers for resistance to KRAS-G12C inhibitors
Effect of clinical characteristics on ORR. A Subgroup analysis of ORR by age; B subgroup analysis of ORR by gender; C subgroup analysis of ORR by dose. QD: once daily; BID: twice daily